Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted descending | Why surfaced |
|---|---|---|---|---|---|---|---|
| PHCBNYSE | Hexor REIT Real Estate | $219M | $0.4M/d | 0 | no coverage | 92 | Capacity-utilization step-up not present in the prior analyst note's model. |
| WDVBPNYSE | Orval Trust Real Estate | $642M | $3.4M/d | 0 | no coverage | 88 | Capacity-utilization step-up not present in the prior analyst note's model. |
| SJRQFNYSE | Aldra Bancshares Financials | $140M | $0.7M/d | 0 | no coverage | 87 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| TRVZFNYSE | Borvel Properties Real Estate | $297M | $0.6M/d | 0 | no coverage | 87 | Capacity-utilization step-up not present in the prior analyst note's model. |
| HUFPNYSE | Quor Holdings Real Estate | $586M | $3.0M/d | 0 | no coverage | 86 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| OAKMNYSE | Oakmoor Bancshares Financials | $198M | $0.6M/d | 0 | no coverage | 84 | CRE concentration plus rate-cycle inflection, no analyst voice since 2024. |
| GEJZNYSE | Penna Holdings Real Estate | $76M | $0.4M/d | 0 | no coverage | 84 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| TJKMNASDAQ | Ulmar Bio Healthcare | $461M | $2.0M/d | 0 | no coverage | 83 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| GQGVNYSE | Penna Bancshares Financials | $505M | $2.8M/d | 0 | no coverage | 83 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| QORMNASDAQ | Qorm Diagnostics Healthcare | $184M | $0.6M/d | 1 | low coverage | 78 | Single sell-side voice; reimbursement code expansion 2026-Q2 not yet modeled by consensus. |
| PGMMTNYSE | Xander Estates Real Estate | $145M | $0.4M/d | 0 | no coverage | 78 | No-coverage screen flag; recent insider buying not yet modeled. |
| KRYONASDAQ | Kryo Storage Healthcare | $168M | $0.7M/d | 1 | low coverage | 76 | Single coverage, governance review opened by audit committee not modeled by sell-side. |
| UCZNNASDAQ | Borvel Therapeutics Healthcare | $351M | $0.9M/d | 0 | no coverage | 75 | Bookings disclosure expanded; consensus model still references the prior format. |
| BWEXNYSE | Sextant Estates Real Estate | $470M | $1.8M/d | 0 | no coverage | 74 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| NVCTNASDAQ | Novicort Bio Healthcare | $178M | $0.8M/d | 1 | low coverage | 73 | Single coverage and Phase 3 readout post-coverage refresh; consensus has stale model. |
| MJQJNASDAQ | Westra Therapeutics Healthcare | $284M | $1.0M/d | 1 | low coverage | 72 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| REPLNASDAQ | Replion Therapeutics Healthcare | $156M | $0.8M/d | 1 | low coverage | 70 | Catalyst-driven cohort, single coverage, no consensus model post-Phase-2 readout. |
| VFUUNASDAQ | Cantil Bio Healthcare | $145M | $0.3M/d | 1 | low coverage | 68 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| NBJPZNASDAQ | Zephir Trust Real Estate | $149M | $0.3M/d | 1 | low coverage | 65 | Channel structure obscures sell-through; alt-data flags acceleration. |
| MBQNNYSE | Falcrest Trust Real Estate | $633M | $2.3M/d | 1 | low coverage | 63 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| TRDMNYSE | Tridem REIT Real Estate | $388M | $1.5M/d | 2 | low coverage | 55 | Tenant credit migration in FY25 not yet flagged by sell-side cohort. |
| PEERCNASDAQ | Ember Sciences Healthcare | $211M | $1.4M/d | 5 | covered | 45 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |